Literature DB >> 18703505

How a T cell receptor-like antibody recognizes major histocompatibility complex-bound peptide.

Tatiana Mareeva1, Erik Martinez-Hackert, Yuri Sykulev.   

Abstract

We determined the crystal structures of the T cell receptor (TCR)-like antibody 25-D1.16 Fab fragment bound to a complex of SIINFEKL peptide from ovalbumin and the H-2K(b) molecule. Remarkably, this antibody directly "reads" the structure of the major histocompatibility complex (MHC)-bound peptide, employing the canonical diagonal binding mode utilized by most TCRs. This is in marked contrast with another TCR-like antibody, Hyb3, bound to melanoma peptide MAGE-A1 in association with HLA-A1 MHC class I. Hyb3 assumes a non-canonical orientation over its cognate peptide-MHC and appears to recognize a conformational epitope in which the MHC contribution is dominant. We conclude that TCR-like antibodies can recognize MHC-bound peptide via two different mechanisms: one is similar to that exploited by the preponderance of TCRs and the other requires a non-canonical antibody orientation over the peptide-MHC complex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18703505      PMCID: PMC2570882          DOI: 10.1074/jbc.M804996200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Determination of the relationship between T cell responsiveness and the number of MHC-peptide complexes using specific monoclonal antibodies.

Authors:  P A Reay; K Matsui; K Haase; C Wulfing; Y H Chien; M M Davis
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

2.  Differences in antigen recognition and cytolytic activity of CD8(+) and CD8(-) T cells that express the same antigen-specific receptor.

Authors:  B K Cho; K C Lian; P Lee; A Brunmark; C McKinley; J Chen; D M Kranz; H N Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

3.  Distinct molecular mechanisms account for the specificity of two different T-cell receptors.

Authors:  Nadja Anikeeva; Tatiana Lebedeva; Michelle Krogsgaard; Sergey Y Tetin; Erik Martinez-Hackert; Spyros A Kalams; Mark M Davis; Yuri Sykulev
Journal:  Biochemistry       Date:  2003-04-29       Impact factor: 3.162

Review 4.  What do TCR-pMHC crystal structures teach us about MHC restriction and alloreactivity?

Authors:  Dominique Housset; Bernard Malissen
Journal:  Trends Immunol       Date:  2003-08       Impact factor: 16.687

5.  High affinity xenoreactive TCR:MHC interaction recruits CD8 in absence of binding to MHC.

Authors:  Jennifer Buslepp; Samantha E Kerry; Doug Loftus; Jeffrey A Frelinger; Ettore Appella; Edward J Collins
Journal:  J Immunol       Date:  2003-01-01       Impact factor: 5.422

6.  Antibody specific for the peptide.major histocompatibility complex. Is it T cell receptor-like?

Authors:  Tatiana Mareeva; Tatiana Lebedeva; Nadia Anikeeva; Tim Manser; Yuri Sykulev
Journal:  J Biol Chem       Date:  2004-08-09       Impact factor: 5.157

7.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution.

Authors:  R Huber; D Kukla; W Bode; P Schwager; K Bartels; J Deisenhofer; W Steigemann
Journal:  J Mol Biol       Date:  1974-10-15       Impact factor: 5.469

8.  Peptide interaction with a class I major histocompatibility complex-encoded molecule: allosteric control of the ternary complex stability.

Authors:  D M Gakamsky; P J Bjorkman; I Pecht
Journal:  Biochemistry       Date:  1996-11-26       Impact factor: 3.162

9.  CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes.

Authors:  I F Luescher; E Vivier; A Layer; J Mahiou; F Godeau; B Malissen; P Romero
Journal:  Nature       Date:  1995-01-26       Impact factor: 49.962

10.  Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells.

Authors:  S C Jameson; F R Carbone; M J Bevan
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

View more
  26 in total

1.  Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363.

Authors:  Esther Dawen Yu; Enrico Girardi; Jing Wang; Thien-Thi Mac; Karl O A Yu; Serge Van Calenbergh; Steven A Porcelli; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

2.  T Cell Receptor Engineering and Analysis Using the Yeast Display Platform.

Authors:  Sheena N Smith; Daniel T Harris; David M Kranz
Journal:  Methods Mol Biol       Date:  2015

3.  TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide/HLA targets.

Authors:  Devin B Lowe; Camille K Bivens; Alexis S Mobley; Christian E Herrera; Amanda L McCormick; Timea Wichner; Manoj K Sabnani; Laurence M Wood; Jon A Weidanz
Journal:  MAbs       Date:  2017 May/Jun       Impact factor: 5.857

Review 4.  T cell receptor bias for MHC: co-evolution or co-receptors?

Authors:  Sneha Rangarajan; Roy A Mariuzza
Journal:  Cell Mol Life Sci       Date:  2014-03-17       Impact factor: 9.261

5.  Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.

Authors:  Ge Ying; Jing Wang; Thierry Mallevaey; Serge Van Calenbergh; Dirk M Zajonc
Journal:  J Biol Chem       Date:  2019-07-11       Impact factor: 5.157

Review 6.  Mechanisms controlling granule-mediated cytolytic activity of cytotoxic T lymphocytes.

Authors:  Nadia Anikeeva; Yuri Sykulev
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

7.  Structure of a TCR-Mimic Antibody with Target Predicts Pharmacogenetics.

Authors:  Niloufar Ataie; Jingyi Xiang; Neal Cheng; Elliott J Brea; Wenjie Lu; David A Scheinberg; Cheng Liu; Ho Leung Ng
Journal:  J Mol Biol       Date:  2015-12-11       Impact factor: 5.469

8.  Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.

Authors:  Pravin Kumar; Ardeschir Vahedi-Faridi; Wolfram Saenger; Andreas Ziegler; Barbara Uchanska-Ziegler
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

9.  A novel T cell receptor single-chain signaling complex mediates antigen-specific T cell activity and tumor control.

Authors:  Jennifer D Stone; Daniel T Harris; Carolina M Soto; Adam S Chervin; David H Aggen; Edward J Roy; David M Kranz
Journal:  Cancer Immunol Immunother       Date:  2014-08-01       Impact factor: 6.968

10.  CD8(+) T cells from mice transnuclear for a TCR that recognizes a single H-2K(b)-restricted MHV68 epitope derived from gB-ORF8 help control infection.

Authors:  Sharvan Sehrawat; Oktay Kirak; Paul-Albert Koenig; Marisa K Isaacson; Sofia Marques; Gunes Bozkurt; J Pedro Simas; Rudolph Jaenisch; Hidde L Ploegh
Journal:  Cell Rep       Date:  2012-04-26       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.